KBC Group NV grew its stake in Amrize Ltd (NYSE:AMRZ – Free Report) by 199.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,026 shares of the company’s stock after purchasing an additional 21,985 shares during the period. KBC Group NV’s holdings in Amrize were worth $1,850,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in AMRZ. Geode Capital Management LLC bought a new position in Amrize in the 2nd quarter valued at approximately $265,000. M&T Bank Corp acquired a new stake in Amrize in the second quarter valued at approximately $205,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of Amrize during the second quarter worth $3,870,000. Gabelli Funds LLC bought a new stake in shares of Amrize during the second quarter worth $1,083,000. Finally, AXA S.A. acquired a new position in shares of Amrize during the second quarter worth $1,065,000.
Insider Buying and Selling
In other news, insider Nollaig Forrest purchased 2,000 shares of the stock in a transaction on Friday, May 22nd. The stock was purchased at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the acquisition, the insider owned 20,139 shares in the company, valued at $1,011,984.75. This trade represents a 11.03% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mario Gross purchased 1,200 shares of the company’s stock in a transaction dated Wednesday, May 20th. The stock was purchased at an average price of $48.63 per share, for a total transaction of $58,356.00. Following the transaction, the insider directly owned 34,747 shares in the company, valued at approximately $1,689,746.61. This trade represents a 3.58% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have acquired 54,920 shares of company stock valued at $2,717,429. Insiders own 0.54% of the company’s stock.
Wall Street Analyst Weigh In
Get Our Latest Analysis on Amrize
Amrize Stock Up 1.9%
Shares of NYSE:AMRZ opened at $49.25 on Friday. The firm has a market cap of $27.24 billion and a P/E ratio of 23.56. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $65.94. The business has a fifty day simple moving average of $52.09 and a 200 day simple moving average of $55.11. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38.
Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The company had revenue of $2.18 billion during the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. The business’s revenue for the quarter was up 4.7% on a year-over-year basis. Analysts predict that Amrize Ltd will post 2.76 earnings per share for the current year.
Amrize Cuts Dividend
The business also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s payout ratio is currently 21.05%.
Amrize Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
